Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest ROE

Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of return on equity. The trailing-twelve-month return on equity at Meridian Bioscience

is 22.58%. Meridian Bioscience's revenue for the same period is $171.20 million. The trailing-twelve-month return on equity at Neogen

is 10.90%. Neogen's operating margin for the same period is 18.46%. The trailing-twelve-month return on equity at Trinity Biotech plc

is 10.77%. Trinity Biotech's profit margin for the same period is 20.71%. The trailing-twelve-month return on equity at Abaxis

is 8.20%. Abaxis' PEG ratio is 2.69.